Table 5.
Association of the Cost of ADRs with Group and Study Participants’ Characteristics
| B | 95% LCI | 95% UCI | Exp (B) | 95% LCI | 95% UCI | p Value | |
|---|---|---|---|---|---|---|---|
| (Intercept) | 9,113 | 8,509 | 9,716 | 9,070 | 4,961 | 16,583 | 0.000 |
| [Group = A]a | −1.682 | −2.207 | −1.157 | 0.186 | 0.11 | 0.315 | 0.000 |
| [Female]a | −0.345 | −0.78 | 0.089 | 0.708 | 0.458 | 1.093 | 0.119 |
| Cycles | −0.062 | −0.112 | −0.012 | 0.94 | 0.894 | 0.988 | 0.015 |
Dependent variable, cost; generalized linear model; Tweedie distribution with log-link function; adjusted by: (intercept), group, gender, chemotherapy cycles; LCI, lower confidence interval; UCI, upper confidence interval.
a
Group B and male was set at 1, as reference case.